Diminishing mRNA Vaccine Responses in Dialysis Patients Diminishing mRNA Vaccine Responses in Dialysis Patients
Immune responses towards SARS-CoV-2 vaccines among patients undergoing hemodialysis may decrease over time, highlighting the potential need for additional doses in this group.Emerging Infectious Diseases (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 27, 2022 Category: Consumer Health News Tags: Infectious Diseases Journal Article Source Type: news

The impact of falls: a qualitative study of the experiences of people receiving haemodialysis - Young HML, Ruddock N, Harrison M, Goodliffe S, Lightfoot CJ, Mayes J, Nixon AC, Greenwood SA, Conroy S, Singh SJ, Burton JO, Smith AC, Eborall H.
This study aimed to explore the experiences of people receiving HD who had fallen in the last six months. A qualitative study, informed by constructivist grounded theory, used semi-str... (Source: SafetyLit)
Source: SafetyLit - April 14, 2022 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

CMS: Agency Information Collection Activities: Submission for OMB Review; Comment Request
The Centers for Medicare& Medicaid Services (CMS) is seeking comment on the following information collections: 1) State-based Exchange Annual Report Tool (SMART) and 2) National Implementation of the In-Center Hemodialysis CAHPS Survey. Comments are due by May 24, 2022. (Source: Federal Register updates via the Rural Assistance Center)
Source: Federal Register updates via the Rural Assistance Center - March 25, 2022 Category: Rural Health Source Type: news

Artio Medical Welcomes New RandD Leaders and Accelerates Development of Amplifi(TM) Vein Dilation System
PRAIRIE VILLAGE, Kan., Feb. 24, 2022 -- (Healthcare Sales & Marketing Network) -- Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, today announced the hiring o... Devices, Personnel Artio Medical, Amplifi Vein Dilation System, hemodialysis, arteriovenous fistula (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - February 24, 2022 Category: Pharmaceuticals Source Type: news

Use of High-Dose Iron in Dialysis in US Tracks PIVOTAL Trial Use of High-Dose Iron in Dialysis in US Tracks PIVOTAL Trial
The 2019 landmark PIVOTAL trial that established the safety and efficacy of higher-dose iron in patients on hemodialysis had little discernable impact on US practice, which already used higher doses.Medscape Medical News (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - February 22, 2022 Category: Transplant Surgery Tags: Nephrology News Source Type: news

Humoral Response in Hemodialysis Patients Stronger With mRNA-1273
WEDNESDAY, Feb. 16, 2022 -- For patients undergoing hemodialysis, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA-1273 vaccine elicits a stronger humoral response than the BNT162b2 vaccine, according to a study published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 16, 2022 Category: Pharmaceuticals Source Type: news

High-Dose IV Iron Reduces MI in Patients on Hemodialysis
WEDNESDAY, Dec. 22, 2021 -- For patients on maintenance hemodialysis, high-dose versus low-dose intravenous (IV) iron can help reduce the risk for myocardial infarction (MI), according to a study published online Dec. 7 in Cardiovascular... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 22, 2021 Category: Pharmaceuticals Source Type: news

A successful experience using labetalol and hemodialysis to treat near-fatal caffeine poisoning: a case report with toxicodynamics - Ou HC, Deng JF, Yang CC, Lin CS, Mao YC, Tsai SH, Ho CH.
We present an 18-year-old male who attempted suicide with 295  mg/kg pure caffeine powder (lethal oral dose: 150-200 mg/kg) and was successfully rescued. He pres... (Source: SafetyLit)
Source: SafetyLit - December 22, 2021 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

ClearGuard HD antimicrobial barrier caps for preventing haemodialysis catheter-related bloodstream infections [MTG62], NICE(published 13th December 2021)
NICE medical technologies guidance addresses specific technologies notified to NICE by companies. The ' case for adoption ' is based on the claimed advantages of introducing the specific technology compared with current management of the condition. This case is reviewed against the evidence submitted and expert advice. If the case for adopting the technology is supported, the specific recommendations are not intended to limit use of other relevant technologies that may offer similar advantages. If the technology is recommended for use in research, the recommendations are not intended to preclude the use of the technology ...
Source: Current Awareness Service for Health (CASH) - December 20, 2021 Category: Consumer Health News Source Type: news

ClearGuard HD antimicrobial barrier caps for preventing haemodialysis catheter-related bloodstream infection - Medical technologies guidance (MTG62)
ClearGuard HD antimicrobial barrier caps are recommended as a cost-saving option for preventing catheter-related bloodstream infections in people with central venous catheters having haemodialysis. Data should be collected on any long-term effect of chlorhexidine exposure. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - December 14, 2021 Category: Consumer Health News Source Type: news

Corrigendum to "Criterion for initiating hemodialysis based on serum caffeine concentration in treating severe caffeine poisoning" [Am J Emerg Med. 2021 Aug;46:70-73] - Yoshizawa T, Kamijo Y, Hanazawa T, Usui K.
The authors regret. The authors would like to apologise for any inconvenience caused. ... (Source: SafetyLit)
Source: SafetyLit - December 13, 2021 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Factors associated with falls in hemodialysis patients: a case-control study - P érez-Gurbindo I, María Álvarez-Méndez A, Pérez-García R, Cobo PA, Carrere MTA.
OBJECTIVE: to identify possible associations between a higher probability of falls among hemodialysis patients and laboratory values, comorbidities, pharmacological treatment, hemodynamic changes, dialysis results and stabilometric alterations. MET... (Source: SafetyLit)
Source: SafetyLit - November 26, 2021 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Are resistance training-induced BDNF in hemodialysis patients associated with depressive symptoms, quality of life, antioxidant capacity, and muscle strength? An insight for the muscle-brain-renal axis - Deus LA, Corr êa HL, Neves RVP, Reis AL, Honorato FS, Silva VL, Souza MK, de Araújo TB, de Gusmão Alves LS, Sousa CV, Reis TL, de Aguiar LS, Simões HG, Prestes J, Melo GF, Rosa TS.
BACKGROUND: Hemodialysis patients are suffering from depressive symptoms. Brain-derived neurotrophic factor (BDNF) levels are negatively associated with depressive symptoms and decrease during a single hemodialysis session. Resistance training (RT) might b... (Source: SafetyLit)
Source: SafetyLit - November 16, 2021 Category: International Medicine & Public Health Tags: Ergonomics, Human Factors, Anthropometrics, Physiology Source Type: news

Lumasiran Effects in Rare Disease Seen Despite Kidney Status Lumasiran Effects in Rare Disease Seen Despite Kidney Status
The first drug to be approved for primary hyperoxaluria type 1 has shown benefit in patients with chronic kidney disease, including those on hemodialysis.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - November 9, 2021 Category: Drugs & Pharmacology Tags: Nephrology News Source Type: news

No benefit of peritoneal dialysis over haemodialysis for uninsured ESKD patients in the USA
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - November 1, 2021 Category: Drugs & Pharmacology Source Type: news